In AD patients, the concentration of the soluble forms of APPα and TNFR1 in the cerebrospinal fluid are decreased due to reduced brain TACE α-secretase activity (Sennvik et al., 2000; Yao et al., 2015). This evidence concerns the gene TNFRSF1A and Alzheimer disease.